NDC 68071-3453-03 - AMLODIPINE BESYLATE 10 mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3453
- Requested NDC
- 68071-3453-03
- Package NDCs from labels
- 68071-3453-2, 68071-3453-9, 68071-3453-3, 68071-3453-03
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMLODIPINE BESYLATE 10 mg - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3453-2 | AMLODIPINE BESYLATE10 mg | 120 in 1 BOTTLE | TABLET | 120 | 3 | |
| 68071-3453-3 | AMLODIPINE BESYLATE10 mg | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 68071-3453-9 | AMLODIPINE BESYLATE10 mg | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3453 | AMLODIPINE BESYLATE 10 MG (AMLODIPINE BESYLATE) TABLET [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, 3 package rows | 20240328_ffe96aa1-db66-33e4-e053-6394a90a7e4e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 41af64c4-b788-d827-e063-6394a90a9157 | 2025-10-21 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | c9693ad5-0fa6-4796-b20b-2021d589a132 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Quallent Pharmaceuticals Health LLC | c262dedb-1d13-4447-9355-f11e1dbbfb4d | 2025-10-13 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 968c611b-43a7-40f0-9ed3-aa67ee88364b | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 6cf5ece4-4d4e-478e-be8f-bd198c6edc5d | 2025-09-29 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 3ce6978a-6ab3-33a9-e063-6294a90a24a1 | 2025-08-21 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Inc. | 1eb78d80-701d-4766-98c3-feee6790de1a | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Direct_Rx | 0c7d1f99-dfe0-7041-e063-6294a90a9705 | 2025-07-11 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | 81d59754-1b36-4f71-aec1-5335b003a96f | 2025-07-01 | Warnings | L11K75P92J |
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 2437a130-d544-6db4-e063-6394a90a0d4d | 2025-06-13 | Warnings, Adverse reactions | 308135 864V2Q084H |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | e9ecbadb-c548-6fe5-e053-2a95a90a7577 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | d058e426-8786-4fd3-a771-992e4558c135 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Ascend Laboratories, LLC | c1204fbe-d086-43cf-bbaa-efec9cd0487c | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Alembic Pharmaceuticals Inc. | 1346631f-e6db-4c5c-a6af-5aa7b80a011d | 2025-05-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Alembic Pharmaceuticals Limited | ecab983e-6ed8-4440-b7b4-7ac4bf39b26c | 2025-05-23 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Strides Pharma Science Limited | 9b76e441-e6a5-4036-8276-b7788ade5c44 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 921096ab-589a-4821-8d91-a6319f4a559a | 2025-04-09 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.